An interventional study of Nutraceutical and Control in Dyslipidemia, sponsored by Fondazione IRCCS Policlinico San Matteo di Pavia. Completed at 1 site in Italy. Open to female participants. Per ClinicalTrials.gov, last updated 2025-05-01.
Sponsored by Fondazione IRCCS Policlinico San Matteo di Pavia · Not applicable, Interventional, and Treatment
Menopause is usually associated with an increase in body weight, a change in body composition and fat distribution and a large number of cardio-metabolic changes, such as hypertension, reduction of insulin-sensitivity and dyslipidaemia. The first-line strategy for these complications is the modification of dietary habits and lifestyle in terms of physical activity. Besides, there is also a growing interest in complementary therapies (i.e. nutraceuticals) that can be used alone or in combination to achieve more consistent results. In this context, preliminary evidence supports the potential role of some compounds of vegetal origin such as berberine, chlorogenic acid and tocotrienols. However, in support of their use, the evidence from good quality trials is limited.
1,073 studies on the registry are indexed under Dyslipidemias; 158 are open to participants now.
This study's enrollment of 63 is below the median of 99 across 842 interventional studies indexed under Dyslipidemias.
Browse Dyslipidemias studies →Fondazione IRCCS Policlinico San Matteo di Pavia is the lead sponsor of 255 studies on the registry; 113 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
Nutritional counseling plus one pill of an active product (Trixy®) containing Berberine, Tocotrienols and Chlorogenic acid
Dietary Supplement: Nutraceutical
Nutritional counseling
Other: Control
Nutritional counseling plus one pill of an active product (Trixy®) containing Berberine, Tocotrienols and Chlorogenic acid
Nutritional counseling
LDL cholesterol
LDL cholesterol
Time frame: 3 months
Insulin resistance
Homeostatic model assessment (HOMA index)
Time frame: 3 months
Total cholesterol
Total cholesterol
Time frame: 3 months
HDL cholesterol
HDL cholesterol
Time frame: 3 months
Blood glucose
Blood glucose
Time frame: 3 months
Serum Insulin
Serum Insulin
Time frame: 3 months
Body weight
Body weight
Time frame: 3 months
Fat distribution
Waist circumference
Time frame: 3 months
Fat Mass
Fat Mass
Time frame: 3 months
Menopausal symptoms
Greene Climacteric Scale
Time frame: 3 months
Quality of life
36-Item Short Form Health Survey (SF-36)
Time frame: 3 months
Plan to share: Undecided
No publications or documents are linked to this record.
This study is completed, as verified in Apr 2025. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Fondazione IRCCS Policlinico San Matteo di Pavia